New nonhormonal therapy shows promise for treating Genitourinary Syndrome of Menopause

New nonhormonal therapy shows promise for treating Genitourinary Syndrome of Menopause

Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM).

CU Anschutz Researchers Develop Potential Nonhormonal Therapy to Repair Vaginal Tissue Damaged by Menopause

Researchers at the University of Colorado Anschutz have developed a promising nonhormonal therapy for women experiencing Genitourinary Syndrome of Menopause (GSM). GSM is a common chronic condition caused by declining estrogen levels that affects the vulva, vagina and urinary tract, leading to symptoms such as vaginal dryness, painful intercourse, and recurrent vaginal and urinary tract infections.